Efficacy Evaluation of a Novel Home-Used Device Based on Multiple Stimulation Technology on Hair Growth in Patients with Androgenetic Alopecia

    Marina Landau, Torello Lotti, Yana Yutskovskaya
    Studysummary This study observed that the Pilogics Hairegen device increased total hair count by 23.2% and terminal hair count by 21.1% in 289 patients with androgenetic alopecia after approximately 20 weeks of use, with no adverse effects reported.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on madridge.org →
    Discuss this study in the Community →

    Related research 6

    1. What’s New in Hair Loss Dermatologic Clinics · 2019
    2. Hair Loss at Injection Sites of Mesotherapy for Alopecia Journal of Cosmetic Dermatology · 2017
    3. Acitretin for the Treatment of Psoriasis: A Case Report of Long-Lasting Alopecia Journal of Psoriasis and Psoriatic Arthritis · 2015
    4. Disorders of Hair DeckerMed Medicine · 2013
    5. Topical Agents for Hair Growth Promotion: What Is Out There? PubMed · 2013
    6. Diseases of the Hair and Scalp Archives of Dermatology · 1994